Carregant...

Influence of a Novel Inhibitor (UM8190) of Prolylcarboxypeptidase (PRCP) on Appetite and Thrombosis

Preclinical pharmacological characterization of a novel inhibitor (UM8190) of prolylcarboxypeptidase (PRCP) was investigated. We synthesized and evaluated a library of proline-based analogs as prospective recombinant PRCP (rPRCP) inhibitors and inhibitors of PRCP-dependent prekallikrein (PK) activat...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Curr Med Chem
Autors principals: Rabey, F. M., Gadepalli, R.S.V.S., Diano, S., Cheng, Q., Tabrizian, T., Gailani, D., Rimoldi, J.M., Shariat-Madar, Z.
Format: Artigo
Idioma:Inglês
Publicat: 2012
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4367813/
https://ncbi.nlm.nih.gov/pubmed/22664251
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!